Global Probiotics Dietary Supplements Market Size study & Forecast, by Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others), By End-user (Infants, Children, Adults, Geriatric), and Regional Analysis, 2023-2030

Global Probiotics Dietary Supplements Market Size study & Forecast, by Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others), By End-user (Infants, Children, Adults, Geriatric), and Regional Analysis, 2023-2030

Global Probiotics Dietary Supplements Market is valued at approximately USD 7.01 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.0% over the forecast period 2023-2030. Probiotics are the natural bacteria that are present in the gut and other regions of the body. These bacteria are crucial for maintaining healthy digestive health by assisting with food digestion and nutrient absorption. They also assist in supporting the immune system by warding off dangerous germs and other diseases. Probiotics are dietary supplements that include live bacteria or yeasts and are intended to support the health of the immune and digestive systems. These supplements are made to include a lot of good bacteria, which can boost overall health and help to restore the normal balance of gut bacteria. The Probiotics Dietary Supplements Market is expanding because of factors such as the strong emphasis on preventive healthcare, rising governmental initiatives for health and nutrition, growing consumer awareness about the health benefits of probiotics, escalating aging population, availability of products in various forms including powders and chewable tablets.

In addition, the rising prevalence of digestive disorders such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and lactose intolerance is acting as a catalyzing factor for market growth across the globe. According to the National Institute of Diabetes and Digestive and Kidney Diseases, in 2018, nearly 68 percent of the global population are patients with lactose malabsorption majorly across Africa and Asia. Likewise, as per OMICS International, in Brazil, around 85% of the population is suffering from lactose intolerance. Moreover, as per Medline Plus, in 2022, more than 30 million American adults are estimated to suffer from lactose intolerance by age 20. Thus, these aforementioned factors are propelling the growth of the Probiotics Dietary Supplements Market during the estimated period. Moreover, the extensive investment in R&D activities, as well as the increasing availability of the product on the various e-commerce platform is presenting various lucrative opportunities over the forecasting years. However, the lack of standardized regulations and the higher product prices are hampering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Frontotemporal Disorders Treatment Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing prevalence of obesity and digestive distress, increasing preference towards the adoption of the supplement products, and growing health awareness among the population. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The rising governmental initiatives for health and nutrition, growing focus on preventive healthcare, and increasing aging population are significantly propelling the market demand across the region.

Major market players included in this report are:
Probi AB
Vitakem Nutraceutical, Inc.
Chr. Hansen Holding A/S
ProbioFerm
Probium LLC
ADM (Archer Daniels Midland Company)
Dr. Joseph Mercola (Mercola Health Resources, LLC)
Deerland Probiotics and Enzymes, Inc.
DSM (Royal DSM N.V.)
BioGaia AB

Recent Developments in the Market:
 In February 2022, Lifeway Foods Inc announced the introduction of the probiotic drink with live and active probiotics. The MSHRM product line provides these drinks in three flavors: lion’s mane golden milk, reishi vanilla, and troop mix wildberry.
 In October 2021, Probians- a new medicine was introduced by Apsen Pharmaceuticals. Bifidobacterium longum Rosell 175 and Lactobacillus helveticus Rosell-52 are both included in the product in combination.
 In February 2021, Probi- the probiotics manufacturer and Perrigo- the over-the-counter health and wellness player announced a semi-exclusive collaboration in order to introduce premium probiotic digestive and immune health concepts across Italy.

Global Probiotics Dietary Supplements Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Form, End-user, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Form:
Chewables & Gummies
Capsules
Powders
Tablets & Softgels
Others
By End-user:
Infants
Children
Adults
Geriatric
By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned

Probi AB
Vitakem Nutraceutical, Inc.
Chr. Hansen Holding A/S
ProbioFerm
Probium LLC
ADM (Archer Daniels Midland Company)
Dr. Joseph Mercola (Mercola Health Resources, LLC)
Deerland Probiotics and Enzymes, Inc.
DSM (Royal DSM N.V.)
BioGaia AB

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.